Page 34 - Škrgat, Sabina, ed. 2022. Severe Asthma - Basic and Clinical Views. Koper: University of Primorska Press. Severe Asthma Forum, 1
P. 34
30. Begemann H, Kaboth W. [Side-ef- 42. Willey RF, Godden DJ, Carmichael J,
fects of cortisone derivatives]. Internist et al. Twice daily inhalation of a new
severe asthma forum 1: severe asthma - basic and clinical views (Berl). 1967 Mar;8(3):85-94. corticosteroid, budesonide, in the treat-
ment of chronic asthma. Eur J Respir
31. Deleterious Effect of ACTH and Cor- Dis Suppl. 1982;122:138-42.
tisone on Tuberculosis. N Engl J Med.
1951 Oct 25;245:662-4. 43. Field HV, Jenkinson PMA, Frame MH,
et al. Asthma treatment with a new cor-
32. Thayer JM. Side effects of cortisone ticosteroid aerosol, budesonide, admin-
and ACTH. Stanford Med Bull. 1952 istered twice daily by spacer inhaler.
Feb;10(1):1-14. Arch Dis Child. 1982 Nov;57(11):864-
6.
33. Fauci AS, Dale DC, Balow JE. Gluco-
corticosteroid therapy: mechanisms of 44. Ellul‐Micallef R, Johansson S. Acute
action and clinical considerations. Ann dose-response studies in bronchial asth-
Intern Med. 1976 Mar;84(3):304-15. ma with a new corticosteroid, budes-
onide. Br J Clin Pharmacol. 1983
34. Chechani V. Corticosteroids in asth- Apr;15(4):419-22.
ma. J Assoc Acad Minor Phys.
1991;2(3):109-17. 45. Rosenhall L, Lundqvist G, Adelroth
E, et al. Comparison between inhaled
35. Gelfand ML. Administration of corti- and oral corticosteroids in patients with
sone by the aerosol method in the treat- chronic asthma. Eur J Respir Dis Suppl.
ment of bronchial asthma. N Engl J 1982;122:154-62.
Med. 1951 Aug 23;245(8):293-4.
46. Fischer J, Ganellin CR. Ana-
36. Arbesman CE, Bonstein HS, Reis- logue-based drug discovery. Weinheim:
man RE. Dexamethasone aerosol ther- Wiley-VCH; 2006. 575 p.
apy for bronchial asthma. 1963 Jul-
Aug;34:354-61. 47. Barnes NC, Marone G, Maria GUDi,
et al. A comparison of fluticasone pro-
37. Lal S, Bhalla KK, Singhal SN, et al. pionate, 1 mg daily, with beclometh-
Comparison of beclomethasone dipro- asone dipropionate, 2 mg daily, in the
pionate aerosol and prednisolone in re- treatment of severe asthma. Interna-
versible airways obstruction. Br Med. tional Study Group. Eur Respir J. 1993
1972 Aug 5;3(5822):314-7. Jun;6(6):877-85.

38. Adams NP, Bestall JC, Jones P. Inhaled 48. Fabbri L, Burge PS, Croonenborgh L,
beclomethasone versus budesonide for et al. Comparison of fluticasone propi-
chronic asthma. Cochrane Database onate with beclomethasone dipropion-
Syst Rev. 2002;2002(1):CD003530. ate in moderate to severe asthma treat-
doi: 10.1002/14651858.CD003530. ed for one year. International Study
Group. Thorax. 1993 Aug;48(8):817-
39. Brown M, Storey G, George WHS. Be- 23.
clomethasone Dipropionate: A New
Steroid Aerosol for the Treatment of 49. Gustafsson P, Tsanakas J, Gold M,
Allergic Asthma. Br Med J. 1972 Mar et al. Comparison of the efficacy and
4;1(5800):585-90. safety of inhaled fluticasone propi-
onate 200 micrograms/day with in-
40. Clark TJH. Effect of beclomethasone haled beclomethasone dipropionate
dipropionate delivered by aerosol in pa- 400 micrograms/day in mild and mod-
tients with asthma. Lancet. 1972 Jun erate asthma. Arch Dis Child. 1993
24;1(7765):1361-4. Aug;69(2):206-11.

41. Domeij B. Pharmaceutical patents in
Europe. The Hague: Kluwer Law In-
ternational; 2000. (Stockholm Studies
in Law; volume 3). 350 p.
   29   30   31   32   33   34   35   36   37   38   39